Mirador Therapeutics Selected Site — Miami, Florida

Mirador Therapeutics Selected Site is a clinical research site located in Miami, Florida, United States 33134.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Mirador Therapeutics Selected Site has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease.

Sponsors: Mirador Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mirador Therapeutics Selected Site?

Mirador Therapeutics Selected Site has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mirador Therapeutics Selected Site conducted?

Mirador Therapeutics Selected Site has 3 clinical trials on record, with 3 currently active. Their work covers Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease.

Is Mirador Therapeutics Selected Site accredited by Crixeo Health?

Mirador Therapeutics Selected Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mirador Therapeutics Selected Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.